JP7713267B2 - 近視を予防または治療するための方法および組成物 - Google Patents

近視を予防または治療するための方法および組成物

Info

Publication number
JP7713267B2
JP7713267B2 JP2024517354A JP2024517354A JP7713267B2 JP 7713267 B2 JP7713267 B2 JP 7713267B2 JP 2024517354 A JP2024517354 A JP 2024517354A JP 2024517354 A JP2024517354 A JP 2024517354A JP 7713267 B2 JP7713267 B2 JP 7713267B2
Authority
JP
Japan
Prior art keywords
myopia
lactic acid
choroidal
acid bacteria
macrophages
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2024517354A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023210657A1 (https=
JPWO2023210657A5 (https=
Inventor
一男 坪田
俊英 栗原
真一 池田
サイ コ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsubota Laboratory Inc
Original Assignee
Tsubota Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsubota Laboratory Inc filed Critical Tsubota Laboratory Inc
Publication of JPWO2023210657A1 publication Critical patent/JPWO2023210657A1/ja
Publication of JPWO2023210657A5 publication Critical patent/JPWO2023210657A5/ja
Priority to JP2025114296A priority Critical patent/JP7808901B2/ja
Application granted granted Critical
Publication of JP7713267B2 publication Critical patent/JP7713267B2/ja
Priority to JP2026003169A priority patent/JP2026063064A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024517354A 2022-04-26 2023-04-25 近視を予防または治療するための方法および組成物 Active JP7713267B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2025114296A JP7808901B2 (ja) 2022-04-26 2025-07-07 近視を予防または治療するための方法および組成物
JP2026003169A JP2026063064A (ja) 2022-04-26 2026-01-13 近視を予防または治療するための方法および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022072596 2022-04-26
JP2022072596 2022-04-26
PCT/JP2023/016344 WO2023210657A1 (ja) 2022-04-26 2023-04-25 近視を予防または治療するための方法および組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025114296A Division JP7808901B2 (ja) 2022-04-26 2025-07-07 近視を予防または治療するための方法および組成物

Publications (3)

Publication Number Publication Date
JPWO2023210657A1 JPWO2023210657A1 (https=) 2023-11-02
JPWO2023210657A5 JPWO2023210657A5 (https=) 2024-11-25
JP7713267B2 true JP7713267B2 (ja) 2025-07-25

Family

ID=88519036

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2024517354A Active JP7713267B2 (ja) 2022-04-26 2023-04-25 近視を予防または治療するための方法および組成物
JP2025114296A Active JP7808901B2 (ja) 2022-04-26 2025-07-07 近視を予防または治療するための方法および組成物
JP2026003169A Pending JP2026063064A (ja) 2022-04-26 2026-01-13 近視を予防または治療するための方法および組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2025114296A Active JP7808901B2 (ja) 2022-04-26 2025-07-07 近視を予防または治療するための方法および組成物
JP2026003169A Pending JP2026063064A (ja) 2022-04-26 2026-01-13 近視を予防または治療するための方法および組成物

Country Status (9)

Country Link
EP (1) EP4516305A4 (https=)
JP (3) JP7713267B2 (https=)
KR (1) KR20250006145A (https=)
CN (1) CN119072322A (https=)
AU (1) AU2023258808A1 (https=)
CA (1) CA3249939A1 (https=)
MX (1) MX2024013133A (https=)
TW (1) TW202400198A (https=)
WO (1) WO2023210657A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7781461B2 (ja) 2023-10-25 2025-12-08 株式会社坪田ラボ 近視を予防または治療するための方法および組成物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025089394A1 (ja) * 2023-10-25 2025-05-01 株式会社坪田ラボ 近視を予防または治療するための方法および組成物
WO2025192737A1 (ja) * 2024-03-15 2025-09-18 株式会社坪田ラボ 脈絡膜菲薄化抑制剤

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107372821A (zh) 2017-07-25 2017-11-24 芜湖职业技术学院 护眼保健酸奶及其制备方法
JP2018043986A (ja) 2016-09-09 2018-03-22 学校法人慶應義塾 眼疲労の抑制又は改善用組成物
CN112493318A (zh) 2020-12-01 2021-03-16 河北三元食品有限公司 一种专用于三周岁以上儿童的全营养奶粉及其制备方法
CN113349257A (zh) 2021-04-13 2021-09-07 石家庄君乐宝乳业有限公司 一种有益于视力保护的发酵乳及其制备方法
WO2022065848A1 (ko) 2020-09-23 2022-03-31 피비엘바이오랩 주식회사 신규 유산균 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3066561B2 (ja) * 1993-10-07 2000-07-17 武田薬品工業株式会社 近視予防・治療剤
TWI658828B (zh) * 2014-10-31 2019-05-11 中國醫藥大學 用於舒緩及減輕近視之醫藥組合物及其製備方法與用途
WO2018164113A1 (ja) * 2017-03-06 2018-09-13 学校法人 慶應義塾 マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤
JP7394737B2 (ja) 2020-10-30 2023-12-08 愛三工業株式会社 燃料供給装置

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018043986A (ja) 2016-09-09 2018-03-22 学校法人慶應義塾 眼疲労の抑制又は改善用組成物
CN107372821A (zh) 2017-07-25 2017-11-24 芜湖职业技术学院 护眼保健酸奶及其制备方法
WO2022065848A1 (ko) 2020-09-23 2022-03-31 피비엘바이오랩 주식회사 신규 유산균 및 이의 용도
CN112493318A (zh) 2020-12-01 2021-03-16 河北三元食品有限公司 一种专用于三周岁以上儿童的全营养奶粉及其制备方法
CN113349257A (zh) 2021-04-13 2021-09-07 石家庄君乐宝乳业有限公司 一种有益于视力保护的发酵乳及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7781461B2 (ja) 2023-10-25 2025-12-08 株式会社坪田ラボ 近視を予防または治療するための方法および組成物

Also Published As

Publication number Publication date
MX2024013133A (es) 2024-12-06
JP7808901B2 (ja) 2026-01-30
KR20250006145A (ko) 2025-01-10
CN119072322A (zh) 2024-12-03
JPWO2023210657A1 (https=) 2023-11-02
JP2025129384A (ja) 2025-09-04
EP4516305A4 (en) 2026-04-08
WO2023210657A1 (ja) 2023-11-02
EP4516305A1 (en) 2025-03-05
CA3249939A1 (en) 2025-06-17
AU2023258808A1 (en) 2024-11-07
JP2026063064A (ja) 2026-04-10
TW202400198A (zh) 2024-01-01

Similar Documents

Publication Publication Date Title
JP7713267B2 (ja) 近視を予防または治療するための方法および組成物
KR101778734B1 (ko) 비피도박테리움 롱검 kacc 91563으로부터 분리된 esbp 및 이를 이용한 항알레르기 조성물
JP2018503597A (ja) その必要がある対象の飽食を誘導し、満腹を延長させる医薬組成物および食品組成物
TW202038978A (zh) 包含細菌菌株之組成物
JP2018503597A5 (https=)
CN115776986A (zh) 新型蛋白质及其治疗和美容用途
KR20190054801A (ko) 카페인산 페네틸 에스테르 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 대장성 질환 예방 또는 치료용 약학적 조성물
HK40112500A (zh) 用於预防或治疗近视的方法及组合物
WO2025089394A1 (ja) 近視を予防または治療するための方法および組成物
US20230149475A1 (en) Composition for preventing, improving, or treating sarcopenia, comprising tenebrio molitor larval protein or hydrolysate thereof as active ingredient
JPWO2007040005A1 (ja) ペルオキシソーム増殖剤応答性受容体ＰＰＡＲα活性化剤、および該活性化剤を含有する特定症状の予防または改善用組成物
JPWO2007040006A1 (ja) ペルオキシソーム増殖剤応答性受容体ＰＰＡＲγ活性化剤、および該活性化剤を含有する特定症状の予防または改善用組成物
JP2016164138A (ja) 筋分化促進組成物
EP4527398A1 (en) Therapeutic use of a postbiotic composition in colon and or lung cancer
EP4438050A1 (en) Postbiotic composition comprising bacterial lysates for oral administration for treating solid tumors
JP7835954B2 (ja) 乳酸菌及び免疫賦活剤
JP7660846B2 (ja) 毛細血管障害抑制剤、毛細血管障害改善剤、及び毛細血管新生促進剤
KR102370176B1 (ko) HopQ를 포함하는 암전이 억제용 조성물
JP2024510608A (ja) 眼障害の治療方法及び眼障害の治療のためのマイクロバイオーム組成物、成分、または代謝産物の使用
JP2025105580A (ja) 免疫賦活剤
RS53996B1 (sr) Kompozicije koje sadrže core-1 pozitivni mikroorganizam i njihova primena za lečenje ili profilaksu tumora
WO2024152194A1 (zh) 1-[4-氯-3-(三氟甲基)苯基]-3-[3-(4-氰基苯氧基)苯基]脲在制备用于预防及/或治疗眼部疾病的医药组合物中的用途
EP4687929A1 (en) Postbiotic composition comprising bacterial lysates for oral administration for treating solid tumors
JP2025118040A (ja) 抗ｉ型アレルギー剤、抗ｉ型アレルギー用組成物、抗ｉ型アレルギー剤の製造方法、抗ｉ型アレルギー用組成物の製造方法及び抗ｉ型アレルギーのために使用する方法
HK40105076A (zh) 微生物组组合物、组分或代谢物用於治疗眼睛病症的方法和用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241108

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241108

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20241108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241202

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250328

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250610

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250707

R150 Certificate of patent or registration of utility model

Ref document number: 7713267

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150